Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-04 · accession 0000950170-24-122084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-06 | 2024-11-04 | HRTX | Kaseta Michael | Dir | A - Grant | — | +37.9K | 37.9K | New | — |
| D | 2024-11-06 | 2024-11-04 | HRTX | Kaseta Michael | Dir | A - Grant | $1.78 | +227.3K | 227.3K | New | +$404.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-04 | A | A | 37,879 | — | 37,879 | D | — | — | (F1) The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (11/4/2024). (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-11-04 | A | A | 227,272 | $1.78 | 227,272 | D | $1.78 · — to 2034-11-04 | 227,272 Common Stock | (F3) The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant (11/4/2024). |